Clinical Trials Directory

Trials / Sponsors / CARsgen Therapeutics Co., Ltd.

CARsgen Therapeutics Co., Ltd.

Industry · 13 registered clinical trials — 5 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingLong Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy
Relapsed or Refractory Multiple Myeloma
—2025-03-31
Not Yet RecruitingA Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Mul
Relapsed/Refractory Multiple Myeloma
—2024-10-01
Not Yet RecruitingAnti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL
Multiple Myeloma, Primary Plasma Cell Leukemia
Phase 1 / Phase 22024-04-15
RecruitingCT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Re
HCC
Phase 12023-10-08
RecruitingA Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer
Pancreatic Cancer
Phase 12023-07-11
Active Not RecruitingClaudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers
Gastric Cancer, Pancreatic Cancer
Phase 1 / Phase 22020-10-23
Active Not RecruitingStudy to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma
Phase 1 / Phase 22020-10-23
CompletedClinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors
Solid Tumor, Gastric Cancer, Pancreatic Adenocarcinoma
Phase 12020-06-04
Active Not RecruitingClinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUM
Multiple Myeloma
Phase 1 / Phase 22019-09-25
CompletedChimeric Antigen Receptor T Cells Targeting Glypican-3
Hepatocellular Carcinoma
Phase 12019-08-15
CompletedClinical Trial to Evaluate CD19 CAR T (CT032) in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell
Refractory B-Cell Non-Hodgkin Lymphoma, Relapsed B-cell Non-Hodgkin Lymphoma
Phase 1 / Phase 22019-08-14
UnknownClinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY
Multiple Myeloma
Phase 1 / Phase 22019-06-10
UnknownAnti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma
Lung Squamous Cell Carcinoma
Phase 12016-03-01